Appili Therapeutics Inc.
APLIF
$0.0264
-$0.0018-6.38%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.96M | -5.78M | -6.31M | -6.97M | -7.64M |
| Total Depreciation and Amortization | 8.90K | 7.50K | 6.10K | 4.70K | 6.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.25M | 1.40M | 1.71M | 1.79M | 1.98M |
| Change in Net Operating Assets | 379.40K | 1.16M | -813.80K | -2.58M | -4.34M |
| Cash from Operations | -2.32M | -3.21M | -5.40M | -7.76M | -10.00M |
| Capital Expenditure | -24.40K | -24.40K | -24.40K | -2.30K | 600.00 |
| Sale of Property, Plant, and Equipment | -2.60K | -2.60K | -2.80K | 100.00 | 2.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -27.00K | -27.00K | -27.20K | -2.20K | 3.30K |
| Total Debt Issued | 2.80M | 2.80M | 2.65M | 2.50M | 4.50M |
| Total Debt Repaid | -93.40K | -87.00K | -88.30K | -85.60K | -3.18M |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 3.21M | 3.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -376.00K | -378.70K | -381.40K | 279.80K | 276.10K |
| Cash from Financing | 1.72M | 1.73M | 1.61M | 4.54M | 3.78M |
| Foreign Exchange rate Adjustments | -1.20K | 0.00 | 6.00K | -5.10K | 71.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -621.00K | -1.51M | -3.81M | -3.24M | -6.14M |
